Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 5,956 Shares

Cardlytics, Inc. (NASDAQ:CDLX) insider Nicholas Hollmeyer Lynton sold 5,956 shares of the firm’s stock in a transaction on Tuesday, July 2nd. The shares were sold at an average price of $7.95, for a total value of $47,350.20. Following the completion of the sale, the insider now owns 78,593 shares in the company, valued at $624,814.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Nicholas Hollmeyer Lynton also recently made the following trade(s):

• On Tuesday, April 23rd, Nicholas Hollmeyer Lynton sold 276 shares of Cardlytics stock. The stock was sold at an average price of $12.76, for a total value of $3,521.76.

Cardlytics Stock Performance

CDLX stock traded down $0.25 during trading on Tuesday, hitting $7.83. The company had a trading volume of 750,273 shares, compared to its average volume of 1,368,857. The firm has a 50-day moving average price of $9.80 and a 200-day moving average price of $9.56. The company has a quick ratio of 2.13, a current ratio of 2.13 and a debt-to-equity ratio of 1.30. The firm has a market cap of $381.95 million, a PE ratio of -1.77 and a beta of 1.65. Cardlytics, Inc. has a 1-year low of $5.69 and a 1-year high of $20.52.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, May 8th. The company reported ($0.35) earnings per share (EPS) for the quarter. Cardlytics had a negative net margin of 55.23% and a negative return on equity of 25.36%. The company had revenue of $67.61 million during the quarter. On average, analysts expect that Cardlytics, Inc. will post -1.8 earnings per share for the current year.

Hedge Funds Weigh In On Cardlytics

Large investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC increased its stake in shares of Cardlytics by 349.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock worth $88,000 after acquiring an additional 7,465 shares during the period. Banco Santander S.A. acquired a new stake in shares of Cardlytics in the 1st quarter valued at approximately $199,000. SG Americas Securities LLC boosted its stake in shares of Cardlytics by 34.3% in the fourth quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock valued at $198,000 after buying an additional 5,484 shares in the last quarter. Clear Street Markets LLC acquired a new position in Cardlytics during the fourth quarter worth $199,000. Finally, Check Capital Management Inc. CA raised its position in Cardlytics by 14.0% in the fourth quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock worth $214,000 after acquiring an additional 2,850 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on CDLX. Lake Street Capital increased their price target on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Bank of America reissued a “neutral” rating and issued a $11.00 price target on shares of Cardlytics in a research report on Thursday, June 20th. Northland Securities started coverage on Cardlytics in a report on Tuesday, June 18th. They set an “outperform” rating and a $14.00 price objective on the stock. Northland Capmk upgraded Cardlytics to a “strong-buy” rating in a research report on Tuesday, June 18th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $12.00 target price on shares of Cardlytics in a report on Tuesday, June 11th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $12.67.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.